ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Surgical Hemostatic Agents Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-4J8250
Home | Market Reports | Health| Medical Devices & Equipment
Global and China Surgical Hemostatic Agents Market Insights Forecast to 2027
BUY CHAPTERS

Global Surgical Hemostatic Agents Market Research Report 2025

Code: QYRE-Auto-4J8250
Report
July 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
J & J
Baxter
BD
Gelita
Pfizer Inc
B. Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic Inc
Z-Medica
Marine Polymer
Equimedical
CryoLife

Surgical Hemostatic Agents Market Size

The global market for Surgical Hemostatic Agents was valued at US$ 4311 million in the year 2024 and is projected to reach a revised size of US$ 6362 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Surgical Hemostatic Agents Market

Surgical Hemostatic Agents Market

Hemostasis, also known as hemorrhage prevention, is the process that stops blood from leaking into a blood vessel. Hemostasis happens when a clot develops at the location of the blood vessel injury, repairing it. This report mainly focuses on surgical hemostatic agents market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Surgical Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Hemostatic Agents.
The Surgical Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Surgical Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Surgical Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Surgical Hemostatic Agents Market Report

Report Metric Details
Report Name Surgical Hemostatic Agents Market
Accounted market size in year US$ 4311 million
Forecasted market size in 2031 US$ 6362 million
CAGR 5.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company J&J, Baxter, BD, Gelita, Pfizer, B Braun, CSL Behring, Ferrosan Medical Devices, Advance Medical Solution, Medtronic, Z-Medica, Marine Polymer, Equimedical, CryoLife
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Surgical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Surgical Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Surgical Hemostatic Agents Market growing?

Ans: The Surgical Hemostatic Agents Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Surgical Hemostatic Agents Market size in 2031?

Ans: The Surgical Hemostatic Agents Market size in 2031 will be US$ 6362 million.

Who are the main players in the Surgical Hemostatic Agents Market report?

Ans: The main players in the Surgical Hemostatic Agents Market are J&J, Baxter, BD, Gelita, Pfizer, B Braun, CSL Behring, Ferrosan Medical Devices, Advance Medical Solution, Medtronic, Z-Medica, Marine Polymer, Equimedical, CryoLife

What are the Application segmentation covered in the Surgical Hemostatic Agents Market report?

Ans: The Applications covered in the Surgical Hemostatic Agents Market report are Hospitals, Surgical Centers, Other

What are the Type segmentation covered in the Surgical Hemostatic Agents Market report?

Ans: The Types covered in the Surgical Hemostatic Agents Market report are Gelation Hemostats, Combination Hemostats, Others

Recommended Reports

Surgical Hemostats

Hemostatic Devices

Adjunctive Hemostats

1 Surgical Hemostatic Agents Market Overview
1.1 Product Definition
1.2 Surgical Hemostatic Agents by Type
1.2.1 Global Surgical Hemostatic Agents Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gelation Hemostats
1.2.3 Combination Hemostats
1.2.4 Others
1.3 Surgical Hemostatic Agents by Application
1.3.1 Global Surgical Hemostatic Agents Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Other
1.4 Global Surgical Hemostatic Agents Market Size Estimates and Forecasts
1.4.1 Global Surgical Hemostatic Agents Revenue 2020-2031
1.4.2 Global Surgical Hemostatic Agents Sales 2020-2031
1.4.3 Global Surgical Hemostatic Agents Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Surgical Hemostatic Agents Market Competition by Manufacturers
2.1 Global Surgical Hemostatic Agents Sales Market Share by Manufacturers (2020-2025)
2.2 Global Surgical Hemostatic Agents Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Surgical Hemostatic Agents Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Surgical Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Surgical Hemostatic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Surgical Hemostatic Agents, Product Type & Application
2.7 Global Key Manufacturers of Surgical Hemostatic Agents, Date of Enter into This Industry
2.8 Global Surgical Hemostatic Agents Market Competitive Situation and Trends
2.8.1 Global Surgical Hemostatic Agents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Surgical Hemostatic Agents Players Market Share by Revenue
2.8.3 Global Surgical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Surgical Hemostatic Agents Market Scenario by Region
3.1 Global Surgical Hemostatic Agents Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Surgical Hemostatic Agents Sales by Region: 2020-2031
3.2.1 Global Surgical Hemostatic Agents Sales by Region: 2020-2025
3.2.2 Global Surgical Hemostatic Agents Sales by Region: 2026-2031
3.3 Global Surgical Hemostatic Agents Revenue by Region: 2020-2031
3.3.1 Global Surgical Hemostatic Agents Revenue by Region: 2020-2025
3.3.2 Global Surgical Hemostatic Agents Revenue by Region: 2026-2031
3.4 North America Surgical Hemostatic Agents Market Facts & Figures by Country
3.4.1 North America Surgical Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Surgical Hemostatic Agents Sales by Country (2020-2031)
3.4.3 North America Surgical Hemostatic Agents Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Surgical Hemostatic Agents Market Facts & Figures by Country
3.5.1 Europe Surgical Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Surgical Hemostatic Agents Sales by Country (2020-2031)
3.5.3 Europe Surgical Hemostatic Agents Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Surgical Hemostatic Agents Market Facts & Figures by Region
3.6.1 Asia Pacific Surgical Hemostatic Agents Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Surgical Hemostatic Agents Sales by Region (2020-2031)
3.6.3 Asia Pacific Surgical Hemostatic Agents Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Surgical Hemostatic Agents Market Facts & Figures by Country
3.7.1 Latin America Surgical Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Surgical Hemostatic Agents Sales by Country (2020-2031)
3.7.3 Latin America Surgical Hemostatic Agents Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Surgical Hemostatic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Surgical Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Surgical Hemostatic Agents Sales by Country (2020-2031)
3.8.3 Middle East and Africa Surgical Hemostatic Agents Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Surgical Hemostatic Agents Sales by Type (2020-2031)
4.1.1 Global Surgical Hemostatic Agents Sales by Type (2020-2025)
4.1.2 Global Surgical Hemostatic Agents Sales by Type (2026-2031)
4.1.3 Global Surgical Hemostatic Agents Sales Market Share by Type (2020-2031)
4.2 Global Surgical Hemostatic Agents Revenue by Type (2020-2031)
4.2.1 Global Surgical Hemostatic Agents Revenue by Type (2020-2025)
4.2.2 Global Surgical Hemostatic Agents Revenue by Type (2026-2031)
4.2.3 Global Surgical Hemostatic Agents Revenue Market Share by Type (2020-2031)
4.3 Global Surgical Hemostatic Agents Price by Type (2020-2031)
5 Segment by Application
5.1 Global Surgical Hemostatic Agents Sales by Application (2020-2031)
5.1.1 Global Surgical Hemostatic Agents Sales by Application (2020-2025)
5.1.2 Global Surgical Hemostatic Agents Sales by Application (2026-2031)
5.1.3 Global Surgical Hemostatic Agents Sales Market Share by Application (2020-2031)
5.2 Global Surgical Hemostatic Agents Revenue by Application (2020-2031)
5.2.1 Global Surgical Hemostatic Agents Revenue by Application (2020-2025)
5.2.2 Global Surgical Hemostatic Agents Revenue by Application (2026-2031)
5.2.3 Global Surgical Hemostatic Agents Revenue Market Share by Application (2020-2031)
5.3 Global Surgical Hemostatic Agents Price by Application (2020-2031)
6 Key Companies Profiled
6.1 J&J
6.1.1 J&J Company Information
6.1.2 J&J Description and Business Overview
6.1.3 J&J Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 J&J Surgical Hemostatic Agents Product Portfolio
6.1.5 J&J Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Surgical Hemostatic Agents Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Surgical Hemostatic Agents Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Gelita
6.4.1 Gelita Company Information
6.4.2 Gelita Description and Business Overview
6.4.3 Gelita Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Gelita Surgical Hemostatic Agents Product Portfolio
6.4.5 Gelita Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Surgical Hemostatic Agents Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 B Braun
6.6.1 B Braun Company Information
6.6.2 B Braun Description and Business Overview
6.6.3 B Braun Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 B Braun Surgical Hemostatic Agents Product Portfolio
6.6.5 B Braun Recent Developments/Updates
6.7 CSL Behring
6.7.1 CSL Behring Company Information
6.7.2 CSL Behring Description and Business Overview
6.7.3 CSL Behring Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CSL Behring Surgical Hemostatic Agents Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 Ferrosan Medical Devices
6.8.1 Ferrosan Medical Devices Company Information
6.8.2 Ferrosan Medical Devices Description and Business Overview
6.8.3 Ferrosan Medical Devices Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ferrosan Medical Devices Surgical Hemostatic Agents Product Portfolio
6.8.5 Ferrosan Medical Devices Recent Developments/Updates
6.9 Advance Medical Solution
6.9.1 Advance Medical Solution Company Information
6.9.2 Advance Medical Solution Description and Business Overview
6.9.3 Advance Medical Solution Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Advance Medical Solution Surgical Hemostatic Agents Product Portfolio
6.9.5 Advance Medical Solution Recent Developments/Updates
6.10 Medtronic
6.10.1 Medtronic Company Information
6.10.2 Medtronic Description and Business Overview
6.10.3 Medtronic Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Medtronic Surgical Hemostatic Agents Product Portfolio
6.10.5 Medtronic Recent Developments/Updates
6.11 Z-Medica
6.11.1 Z-Medica Company Information
6.11.2 Z-Medica Description and Business Overview
6.11.3 Z-Medica Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Z-Medica Surgical Hemostatic Agents Product Portfolio
6.11.5 Z-Medica Recent Developments/Updates
6.12 Marine Polymer
6.12.1 Marine Polymer Company Information
6.12.2 Marine Polymer Description and Business Overview
6.12.3 Marine Polymer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Marine Polymer Surgical Hemostatic Agents Product Portfolio
6.12.5 Marine Polymer Recent Developments/Updates
6.13 Equimedical
6.13.1 Equimedical Company Information
6.13.2 Equimedical Description and Business Overview
6.13.3 Equimedical Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Equimedical Surgical Hemostatic Agents Product Portfolio
6.13.5 Equimedical Recent Developments/Updates
6.14 CryoLife
6.14.1 CryoLife Company Information
6.14.2 CryoLife Description and Business Overview
6.14.3 CryoLife Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CryoLife Surgical Hemostatic Agents Product Portfolio
6.14.5 CryoLife Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Surgical Hemostatic Agents Industry Chain Analysis
7.2 Surgical Hemostatic Agents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Surgical Hemostatic Agents Production Mode & Process Analysis
7.4 Surgical Hemostatic Agents Sales and Marketing
7.4.1 Surgical Hemostatic Agents Sales Channels
7.4.2 Surgical Hemostatic Agents Distributors
7.5 Surgical Hemostatic Agents Customer Analysis
8 Surgical Hemostatic Agents Market Dynamics
8.1 Surgical Hemostatic Agents Industry Trends
8.2 Surgical Hemostatic Agents Market Drivers
8.3 Surgical Hemostatic Agents Market Challenges
8.4 Surgical Hemostatic Agents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
J & J
Baxter
BD
Gelita
Pfizer Inc
B. Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic Inc
Z-Medica
Marine Polymer
Equimedical
CryoLife
List of Tables
 Table 1. Global Surgical Hemostatic Agents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Surgical Hemostatic Agents Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Surgical Hemostatic Agents Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Surgical Hemostatic Agents Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Surgical Hemostatic Agents Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Surgical Hemostatic Agents Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Surgical Hemostatic Agents Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Surgical Hemostatic Agents Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Surgical Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Surgical Hemostatic Agents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Surgical Hemostatic Agents, Product Type & Application
 Table 12. Global Key Manufacturers of Surgical Hemostatic Agents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Surgical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Hemostatic Agents as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Surgical Hemostatic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Surgical Hemostatic Agents Sales by Region (2020-2025) & (K Units)
 Table 18. Global Surgical Hemostatic Agents Sales Market Share by Region (2020-2025)
 Table 19. Global Surgical Hemostatic Agents Sales by Region (2026-2031) & (K Units)
 Table 20. Global Surgical Hemostatic Agents Sales Market Share by Region (2026-2031)
 Table 21. Global Surgical Hemostatic Agents Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Surgical Hemostatic Agents Revenue Market Share by Region (2020-2025)
 Table 23. Global Surgical Hemostatic Agents Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Surgical Hemostatic Agents Revenue Market Share by Region (2026-2031)
 Table 25. North America Surgical Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Surgical Hemostatic Agents Sales by Country (2020-2025) & (K Units)
 Table 27. North America Surgical Hemostatic Agents Sales by Country (2026-2031) & (K Units)
 Table 28. North America Surgical Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Surgical Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Surgical Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Surgical Hemostatic Agents Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Surgical Hemostatic Agents Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Surgical Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Surgical Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Surgical Hemostatic Agents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Surgical Hemostatic Agents Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Surgical Hemostatic Agents Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Surgical Hemostatic Agents Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Surgical Hemostatic Agents Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Surgical Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Surgical Hemostatic Agents Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Surgical Hemostatic Agents Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Surgical Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Surgical Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Surgical Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Surgical Hemostatic Agents Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Surgical Hemostatic Agents Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Surgical Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Surgical Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Surgical Hemostatic Agents Sales (K Units) by Type (2020-2025)
 Table 51. Global Surgical Hemostatic Agents Sales (K Units) by Type (2026-2031)
 Table 52. Global Surgical Hemostatic Agents Sales Market Share by Type (2020-2025)
 Table 53. Global Surgical Hemostatic Agents Sales Market Share by Type (2026-2031)
 Table 54. Global Surgical Hemostatic Agents Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Surgical Hemostatic Agents Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Surgical Hemostatic Agents Revenue Market Share by Type (2020-2025)
 Table 57. Global Surgical Hemostatic Agents Revenue Market Share by Type (2026-2031)
 Table 58. Global Surgical Hemostatic Agents Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Surgical Hemostatic Agents Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Surgical Hemostatic Agents Sales (K Units) by Application (2020-2025)
 Table 61. Global Surgical Hemostatic Agents Sales (K Units) by Application (2026-2031)
 Table 62. Global Surgical Hemostatic Agents Sales Market Share by Application (2020-2025)
 Table 63. Global Surgical Hemostatic Agents Sales Market Share by Application (2026-2031)
 Table 64. Global Surgical Hemostatic Agents Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Surgical Hemostatic Agents Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Surgical Hemostatic Agents Revenue Market Share by Application (2020-2025)
 Table 67. Global Surgical Hemostatic Agents Revenue Market Share by Application (2026-2031)
 Table 68. Global Surgical Hemostatic Agents Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Surgical Hemostatic Agents Price (US$/Unit) by Application (2026-2031)
 Table 70. J&J Company Information
 Table 71. J&J Description and Business Overview
 Table 72. J&J Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. J&J Surgical Hemostatic Agents Product
 Table 74. J&J Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Baxter Surgical Hemostatic Agents Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BD Surgical Hemostatic Agents Product
 Table 84. BD Recent Developments/Updates
 Table 85. Gelita Company Information
 Table 86. Gelita Description and Business Overview
 Table 87. Gelita Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Gelita Surgical Hemostatic Agents Product
 Table 89. Gelita Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Surgical Hemostatic Agents Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. B Braun Company Information
 Table 96. B Braun Description and Business Overview
 Table 97. B Braun Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. B Braun Surgical Hemostatic Agents Product
 Table 99. B Braun Recent Developments/Updates
 Table 100. CSL Behring Company Information
 Table 101. CSL Behring Description and Business Overview
 Table 102. CSL Behring Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CSL Behring Surgical Hemostatic Agents Product
 Table 104. CSL Behring Recent Developments/Updates
 Table 105. Ferrosan Medical Devices Company Information
 Table 106. Ferrosan Medical Devices Description and Business Overview
 Table 107. Ferrosan Medical Devices Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Ferrosan Medical Devices Surgical Hemostatic Agents Product
 Table 109. Ferrosan Medical Devices Recent Developments/Updates
 Table 110. Advance Medical Solution Company Information
 Table 111. Advance Medical Solution Description and Business Overview
 Table 112. Advance Medical Solution Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Advance Medical Solution Surgical Hemostatic Agents Product
 Table 114. Advance Medical Solution Recent Developments/Updates
 Table 115. Medtronic Company Information
 Table 116. Medtronic Description and Business Overview
 Table 117. Medtronic Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Medtronic Surgical Hemostatic Agents Product
 Table 119. Medtronic Recent Developments/Updates
 Table 120. Z-Medica Company Information
 Table 121. Z-Medica Description and Business Overview
 Table 122. Z-Medica Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Z-Medica Surgical Hemostatic Agents Product
 Table 124. Z-Medica Recent Developments/Updates
 Table 125. Marine Polymer Company Information
 Table 126. Marine Polymer Description and Business Overview
 Table 127. Marine Polymer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Marine Polymer Surgical Hemostatic Agents Product
 Table 129. Marine Polymer Recent Developments/Updates
 Table 130. Equimedical Company Information
 Table 131. Equimedical Description and Business Overview
 Table 132. Equimedical Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Equimedical Surgical Hemostatic Agents Product
 Table 134. Equimedical Recent Developments/Updates
 Table 135. CryoLife Company Information
 Table 136. CryoLife Description and Business Overview
 Table 137. CryoLife Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. CryoLife Surgical Hemostatic Agents Product
 Table 139. CryoLife Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Surgical Hemostatic Agents Distributors List
 Table 143. Surgical Hemostatic Agents Customers List
 Table 144. Surgical Hemostatic Agents Market Trends
 Table 145. Surgical Hemostatic Agents Market Drivers
 Table 146. Surgical Hemostatic Agents Market Challenges
 Table 147. Surgical Hemostatic Agents Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Surgical Hemostatic Agents
 Figure 2. Global Surgical Hemostatic Agents Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Surgical Hemostatic Agents Market Share by Type: 2024 & 2031
 Figure 4. Gelation Hemostats Product Picture
 Figure 5. Combination Hemostats Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Surgical Hemostatic Agents Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Surgical Hemostatic Agents Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Surgical Centers
 Figure 11. Other
 Figure 12. Global Surgical Hemostatic Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Surgical Hemostatic Agents Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Surgical Hemostatic Agents Sales (2020-2031) & (K Units)
 Figure 15. Global Surgical Hemostatic Agents Average Price (US$/Unit) & (2020-2031)
 Figure 16. Surgical Hemostatic Agents Report Years Considered
 Figure 17. Surgical Hemostatic Agents Sales Share by Manufacturers in 2024
 Figure 18. Global Surgical Hemostatic Agents Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Surgical Hemostatic Agents Players: Market Share by Revenue in Surgical Hemostatic Agents in 2024
 Figure 20. Surgical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Surgical Hemostatic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Surgical Hemostatic Agents Sales Market Share by Country (2020-2031)
 Figure 23. North America Surgical Hemostatic Agents Revenue Market Share by Country (2020-2031)
 Figure 24. United States Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Surgical Hemostatic Agents Sales Market Share by Country (2020-2031)
 Figure 27. Europe Surgical Hemostatic Agents Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Surgical Hemostatic Agents Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Surgical Hemostatic Agents Revenue Market Share by Region (2020-2031)
 Figure 35. China Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Surgical Hemostatic Agents Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Surgical Hemostatic Agents Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Surgical Hemostatic Agents Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Surgical Hemostatic Agents Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Surgical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Surgical Hemostatic Agents by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Surgical Hemostatic Agents by Type (2020-2031)
 Figure 57. Global Surgical Hemostatic Agents Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Surgical Hemostatic Agents by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Surgical Hemostatic Agents by Application (2020-2031)
 Figure 60. Global Surgical Hemostatic Agents Price (US$/Unit) by Application (2020-2031)
 Figure 61. Surgical Hemostatic Agents Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Hemostasis Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostat Powder and Tissue Sealing Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostasis and Tissue Sealing Agents Market Insights Forecast to 2030
Hemostat Powder and Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostatic and Tissue Sealing Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostatic Agents and Tissue Sealants Market Research Report 2025
Global General Surgery Hemostatic Agents Market Research Report 2024
Surgical Hemostats Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tissue Sealing Agents and Hemostasis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Surgical Hemostatic Material Market Research Report 2025
Global Hemostasis Diagnostic Device Market Research Report 2025
Global Hemostatic Sealants Market Research Report 2025
Global Absorbable Hemostatic Agents Market Research Report 2024
Powder Absorbable Hemostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostatic Powders and Hemostatic Agents Market Research Report 2025
Medical Hemostatic Agents Market
Active Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostatic Sealants and Hemostatic Patches Market Research Report 2025
Global Wound Surgery Hemostatic Agents Market Research Report 2024
Global Medical Topical Hemostatic Agent Market Research Report 2025

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions